Reducing Cardiovascular Mortality Through Prevention and Management of Raised Blood Pressure: A World Heart Federation Roadmap

Global Heart

Volumn 10, Issue 2, 2015, Pages 111-122

  Adler, Alma J ^a,h   Prabhakaran, Dorairaj ^b   Bovet, Pascal ^c   Kazi, Dhruv S ^d   Mancia, Giuseppe ^e   Mungal Singh, Vash ^f   Poulter, Neil ^g  

^a WORLD HEART FEDERATION   (Switzerland)

^b PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f Heart and Stroke Foundation of Southern Africa   (South Africa)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DECISION SUPPORT SYSTEM; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HEALTH AUXILIARY; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INFORMATION SYSTEM; MEDICAL EDUCATION; MEDICATION COMPLIANCE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING; SYSTOLIC BLOOD PRESSURE; TELEHEALTH; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL DECISION SUPPORT SYSTEM; DRUG EFFECTS; HEALTH CARE PLANNING; MORTALITY; PRACTICE GUIDELINE; STANDARDS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DECISION SUPPORT SYSTEMS, CLINICAL; GUIDELINES AS TOPIC; HEALTH PLANNING ORGANIZATIONS; HUMANS; HYPERTENSION;

EID: 84955285983     PISSN: 22118160     EISSN: 22118179     Source Type: Journal    
DOI: 10.1016/j.gheart.2015.04.006     Document Type: Editorial

References (40)

1. World Health Organization. A Global Brief on Hypertension: Silent killer, global public health crisis. Available at: http://apps.who.int/iris/bitstream/10665/79059/1/WHO-DCO-WHD-2013.2-eng.pdf. Accessed April 7, 2015.
2. G.M. Singh, G. Danaei, F. Farzadfar et al. The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis PLoS ONE 8 7 2013 e65174
3. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 385 2015 117 171
4. C.J. Murray, A.D. Lopez Measuring the global burden of disease N Engl J Med 369 5 2013 Aug 1 448 457
5. G. Danaei, M.M. Finucane, J.K. Lin National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants Lancet 377 2011 568 577
6. World Health Organization. Global status report on noncommunicable diseases 2010. Available at: www.who.int/nmh/publications/ncd-report-full-en.pdf. Accessed April 7, 2015.
7. R. Lozano, M. Naghavi, K.T. Foreman et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
8. C.K. Chow, K.K. Teo, S. Rangarajan et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries JAMA 310 2013 959 968
9. M.J. O'Donnell, D. Xavier, L. Liu et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study Lancet 376 2010 112 123
10. World Health Organization. Prevention of Cardiovascular Disease Guidelines for assessment and management of cardiovascular risk. 2007. Available at http://ish-world.com/downloads/activities/71665-71665-OMS-INT-RETIRATION.pdf Accessed April 7, 2015.
11. R. Collins, R. Peto, J. Godwin, S. MacMahon Blood pressure and coronary heart disease Lancet 336 1990 370 371
12. Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC) Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data Lancet 384 2014 591 598
13. M.R. Law, J.K. Morris, N.J. Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665
14. B.M. Egan, J. Li, J. Small, P.J. Nietert, A. Sinopoli The growing gap in hypertension control between insured and uninsured adults: national health and nutrition examination survey 1988 to 2010 Hypertension 64 2014 997 1004
15. E. Falaschetti, J. Mindell, C. Knott, N. Poulter Hypertension management in England: a serial cross-sectional study from 1994 to 2011 Lancet 383 2014 1912 1919
16. R. Nieuwlaat, J.D. Schwalm, R. Khatib, S. Yusuf Why are we failing to implement effective therapies in cardiovascular disease? Eur Heart J 34 2013 1262 1269
17. G. Wang, D. Labarthe The cost-effectiveness of interventions designed to reduce sodium intake J Hypertens 29 2011 1693 1699
18. C.M. Spangler-Smith, J.L. Juusola, E.A. Enns, D.K. Owens, A.M. Garber Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis Ann Intern Med 152 2010 481 487
19. V. Mohan, Y.K. Seedat, R. Pradeepa The rising burden of diabetes and hypertension in Southeast Asian and African Regions: Need for effective strategies for prevention and control in primary health care settings Int J Hypertens 2013 2013 409083
20. R. Agarwal, J.E. Bills, T.J.W. Hecht, R.P. Light Home blood pressure monitoring and hypertension control Hypertension 57 2011 29 38
21. M.A. Piper, C.V. Evans, B.U. Burda, K.L. Margolis, E. O'Connor, E.P. Whitlock Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 162 2015 192 204
22. S.E. Burgess, E.J. MacLaughlin, P.A. Smith, A. Salcido, T.J. Benton Blood pressure rising: differences between current clinical and recommended measurement techniques J Am Soc Hypertens 5 2011 484 488
23. T. Krause, K. Lovibond, M. Caulfield et al. Management of hypertension: summary of NICE guidance BMJ 343 2011 d4891
24. R. Khatib, J.D. Schwalm, S. Yusuf et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies PLoS One 15 2014 1
25. K. Ohene Buabeng, L. Matowe, J. Plange-Rhule Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana J Pharm Pharm Sci 7 2004 350 352
26. Z.U.D. Babar, M.I. Ibrahim, H. Singh, N.I. Bukahri, A. Creese Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia PLoS Med 4 2007 e82
27. T.H. Jafar, J. Hatcher, N.R. Poulter et al. Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial Ann Intern Med 151 2009 593 601
28. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Available at: http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236-eng.pdf. Accessed April 7, 2015.
29. World Health Organization. Implementation tools: package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings. Available at: http://apps.who.int/iris/bitstream/10665/133525/1/9789241506557-eng.pdf. Accessed April 7, 2015.
30. A.D. Ambaw, G.A. Alemie, S.M.W. Yohannes, Z.B. Mengesha Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia BMC Public Health 12 2012 282
31. D.S. Kazi, D. Prabhakaran, A.F. Bolger Rising above the rhetoric: mobile applications and the delivery of cost-effective cardiovascular care in resource-limited settings Future Cardiol 11 2015 1 4
32. International Telecommunication Union. Be he@lthy, be mobile. Available at: www.itu.int/en/ITU-D/ICT-Applications/eHEALTH/Be-healthy/Pages/Be-Healthy.aspx. Accessed April 7, 2015.
33. R. Anchala, M.P. Pinto, A. Shroufi et al. The role of decision support system (DSS) in prevention of cardiovascular disease: a systematic review and meta-analysis PLoS ONE 7 2012 e47064
34. R. Anchala, S. Kaptoge, H. Pant, E. Di Angelantonio, O.H. Franco, D. Prabhakaran Evaluation of effectiveness and cost-effectiveness of a clinical decision support system in managing hypertension in resource constrained primary health care settings: results from a cluster randomized trial J Am Heart Assoc 4 2015 e001213
35. V.S. Ajay, M. Tian, H. Chen et al. A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale BMC Public Health 14 2014 924
36. Global Alliance for Chronic Diseases. Hypertension Program Project 2. Available at: https://www.ucl.ac.uk/gacd/projects/current-projects/hypertension/project-pages/project2. Accessed April 7, 2015.
37. P. Ordunez, R. Martinez, M. Niebylski, N. Campbell Hypertension prevention and control in Latin America and the Caribbean J Clin Hypertens (Greenwich) 2015 Feb 28 [Epub ahead of print]
38. Organisation of Eastern Caribbean States. About PPS. Available at: http://www.oecs.org/about-pps?showall=&limitstart=. Accessed April 7, 2015.
39. World Health Organization. STEPwise approach to noncommunicable disease risk factor surveillance (STEPS). Available at: www.who.int/chp/steps/riskfactor/en/. Accessed April 7, 2015.
40. World Heart Federation A roadmap for reducing cardiovascular premature mortality through secondary prevention interventions Global Heart 2015